Rapport Therapeutics, Inc. RAPP Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s total current liabilities?
- Rapport Therapeutics, Inc. (RAPP) reported total current liabilities of $17.9M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Rapport Therapeutics, Inc.'s total current liabilities increased by 90.7% year-over-year, from $9.38M to $17.9M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total current liabilities?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total current liabilities has grown at a 47.1% compound annual growth rate (CAGR), from $8.8M to $19.05M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.